DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹6,840 Cr | ₹5,785 Cr | ₹5,113 Cr | ₹5,009 Cr | ₹4,596 Cr |
What is the latest Total Non-Current Assets ratio of DIVIS LABORATORIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹6,840 Cr |
| Mar2024 | ₹5,785 Cr |
| Mar2023 | ₹5,113 Cr |
| Mar2022 | ₹5,009 Cr |
| Mar2021 | ₹4,596 Cr |
How is Total Non-Current Assets of DIVIS LABORATORIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,840 Cr | 18.24 | |
| Mar2024 | ₹5,785 Cr | 13.14 | |
| Mar2023 | ₹5,113 Cr | 2.08 | |
| Mar2022 | ₹5,009 Cr | 8.97 | |
| Mar2021 | ₹4,596 Cr | - | |
Compare Total Non-Current Assets of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹179,240.4 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,803.0 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,417.0 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
| MANKIND PHARMA | ₹102,256.0 Cr | 3% | 0.8% | 7.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -0.2% |
-0.1% |
3.1% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses